Method for making variant secreted proteins with altered properties
AssigneeGenentech, Inc.
InventorsDavid V. Goeddel, Glenn C. Rice, David W. H. Leung
Life of this patent
Estimating the term…
Loading patent…
AssigneeGenentech, Inc.
InventorsDavid V. Goeddel, Glenn C. Rice, David W. H. Leung
Estimating the term…
A screening method for the selection of mutagenized proteins that are normally secreted by cells is described. The method includes the development of a cloning vector for the expression of secretory proteins as fusion proteins on the cell surface of transfected mammalian cells. The secreted protein is displayed on the cell surface by fusion with the glycophospholipid membrane anchor of decay accelerating factor (DAF). Tissue-type plasminogen activator (t-PA), which is normally secreted, is used as a model protein. PCR mutagenesis is used to generate random mutations within the Kringle 1 (K1) domain of t-PA. Fluorescence activated cell sorting (FACS) is employed to screen for t-PA mutants possessing a loss of an epitope to a specific Mab, whose nonlinear binding domains overlap with the t-PA clearance receptor contact regions novel t-PA mutants designated N115S, N1425S, and K159R were discovered by this method.
A method for making a variant secretory protein retaining at least one desired binding property and eliminating at least one undesired binding property of the wild-type secretory protein comprising:
Dependencies are inferred from the claim text.